dr. oh discusses choosing abiraterone in prostate cancer
Published 6 years ago • 316 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
1:41
dr. oh on abiraterone versus docetaxel in prostate cancer
-
1:32
dr. hahn discusses abiraterone versus docetaxel in prostate cancer
-
1:15
dr. oh on the hormone-sensitive setting in prostate cancer
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
1:17
dr. oh on the safety profile of docetaxel in prostate cancer
-
1:12
dr. oh on the management of hormone-sensitive prostate cancer
-
1:29
dr. oh on recognizing symptom burden in advanced prostate cancer
-
1:22
dr. william oh discusses dasatinib in metastatic castration-resistant prostate cancer
-
0:59
dr. crawford on abiraterone versus enzalutamide in prostate cancer
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
1:22
dr. bryce on the use of abiraterone versus docetaxel in patients with prostate cancer
-
1:13
dr. william oh on combination therapy studies in prostate cancer
-
0:45
dr. hahn on patients with prostate cancer whom neither docetaxel or abiraterone is an option
-
8:56
abiraterone in metastatic prostate cancer
-
1:43
dr. oh on the role of docetaxel in metastatic hormone-sensitive prostate cancer
-
1:02
dr. oh on choosing ar-targeted therapy versus chemotherapy in mhspc
-
1:14
dr. robert dreicer discusses using abiraterone acetate
-
1:08
dr. graff on the use of abiraterone in metastatic prostate cancer